Due to some routine maintenance you might experience temporary service interruptions or slowness on
Sunday, July 19, 2026, 2:00 - 10:00 am (EDT).
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com.
See More
Due to some routine maintenance you might experience temporary service interruptions or slowness on
Sunday, July 19, 2026, 2:00 - 10:00 am (EDT).
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com.
See MoreDue to some routine maintenance you might experience temporary service interruptions or slowness on
Sunday, July 19, 2026, 2:00 - 10:00 am (EDT)
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Western blot analysis of Bcl-2. A Jurkat cell lysate (Human T-cell leukemia; ATCC TIB-152) was probed with the hamster anti-human Bcl-2 antibody at concentrations of 3.0 µg/mL (lane 1), 1.0 µg/mL (lane 2), and 0.5 µg/mL (lane 3). Bcl-2 can be identified as a band of ~ 26 kDa.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Bcl-2 is considered to be novel among proto-oncogenes because it blocks apoptosis (programmed cell death) in many cell types. Apoptosis is an active form of cellular suicide that typically requires new RNA and protein synthesis and is associated with distinct morphological changes including cell shrinkage, cytoplasm membrane blebbing, nuclear fragmentation and DNA degradation. The Bcl-2 gene was first found in t(14:18) containing follicular B-cell lymphomas. A high proportion of these lymphomas contains t(14:18) chromosomal translocations involving the human Bcl-2 gene. Translocation of Bcl-2 sequences from chromosome 18 onto the transcriptionally active immunoglobulin locus at chromosome band 14q32 in B-cells deregulates Bcl-2 gene expression, resulting in high levels of Bcl-2 mRNA and protein expression. Because Bcl-2 blocks apoptosis it may contribute to tumorigenesis by prolonged cell survival rather than by accelerating the rate of cell proliferation. The reduced molecular weight of Bcl-2 is 26 kDa. Additional minor bands at 27-31 kDa and 18-21 kDa may also be observed.
Store both the hamster anti-human Bcl-2 antibody (component 51-1513GR) and the Jurkat cell lysate (component 51-16526N) undiluted at -20°C.
Western blot: Please refer to http://www.bdbiosciences.com/pharmingen/protocols/Western_Blotting.shtml
| Description | Quantity/Size | Part Number | Clone | Isotype |
|---|---|---|---|---|
| Purified Hamster Anti-Human Bcl-2 | 50 µg (1 ea) | 51-1513GR | 6C8 | IgG2, κ |
| Jurkat Cell Lysate | 50 µg (1 ea) | 51-16526N | N/A | N/A |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.